Hearing loss and congenital symptomatic cytomegalovirus infection: a case report of multidisciplinary longitudinal assessment and intervention.
More than 6000 children born annually in this country have hearing loss resulting from congenital cytomegalovirus (CMV) infection, the leading nonhereditary congenital cause of hearing loss in children. This exemplary congenital symptomatic CMV case focuses on the results of longitudinal audiologic, educational, medical, psychological, and visual evaluations and intervention. Decreased ocular motor control and visual acuity were observed as was bilateral deterioration of hearing from 3 days though 9 years of age. Treatment with dexamethasone and histamine resulted in almost complete reversal of the most recent progression of hearing loss in the left ear.
McCollister
F P
FP
University of Alabama College of Education, Tuscaloosa 35487-0231, USA.
Simpson
L C
LC
Dahle
A J
AJ
Pass
R F
RF
Fowler
K B
KB
Amos
C S
CS
Boll
T J
TJ
D000284:Administration, Oral; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001301:Audiometry, Pure-Tone; D002648:Child; D003587:Cytomegalovirus / Q000302:isolation & purification*; D003586:Cytomegalovirus Infections / Q000150:complications / Q000188:drug therapy; D002658:Developmental Disabilities / Q000175:diagnosis; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D004521:Educational Measurement; D016057:Evoked Potentials, Auditory, Brain Stem; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000151:congenital* / Q000175:diagnosis / Q000821:virology*; D006801:Humans; D008137:Longitudinal Studies; D010348:Patient Care Team; D010976:Platelet Count
D000893:Anti-Inflammatory Agents; D003907:Dexamethasone